XML 71 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Operating activities:    
Net income/ (loss) $ 7,687 $ (9,814)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activitites:    
Share-based compensation 131 293
Depreciation 1,152 1,165
Debt related amortization expense 2,118 2,876
Intangibles and other amortization expense 32 124
Change in fair value of warrant liability 48 (162)
Loss on extinguishment of debt 115 956
Gain on sale of assets    (126)
Changes in operating assets and liabilities:    
Accounts receivable 468 700
Inventory 50 182
Prepaid expenses (18) 202
Other current assets and other assets (399) (581)
Accounts payable (1,453) (2,590)
Accrued interest expense and fees, net of payments 145 2,422
Other liabilities 1,178 397
Net cash provided by (used in) in operating activities 11,254 (3,956)
Investing activities:    
Capital expenditures (247) (29)
Proceeds from the sale of assets    400
Net cash (used in) provided by in investing activities (247) 371
Financing activities:    
Proceeds from borrowings 960 4,452
Repayments of borrowings (9,581) (1,259)
Net cash (used in) provided by financing activities (8,621) 3,193
Effect of exchange rate changes on cash and cash equivalents 6 153
Net cash and cash equivalents increase (decrease) for period 2,392 (239)
Cash and cash equivalents at beginning of period 4,926 291
Cash and cash equivalents at end of period 7,318 52
Supplemental disclosures of cash flow information, cash paid:    
Interest payments 2,646 134
Income taxes expense 6 6
Supplemental disclosures of cash flow information, non-cash transactions:    
Proceeds from exercise of stock options applied to accounts payable 16   
Issuance of warrants to subordinated debt holders 95 995
Transfer between debt and other liabilities 438   
Stock issued in connection with services 506   
Payments of principal, fees and interest paid in Stock    1,422
Warrant liability transferred to equity upon exercise    $ 1,007